Financial Disclosures for Pharmacy Services. The MCO must disclose all financial terms and arrangements for remuneration of any kind that apply between the MCO and any prescription drug manufacturer or labeler, including, without limitation, formulary management, drug-switch programs, educational support, claims processing, pharmacy network fees, data sales fees, and any other fees. Article 9 of Attachment A, “Uniform Managed Care Contract Terms and Conditions,” provides HHSC with the right to audit such information at any time. HHSC agrees to maintain the confidentiality of information disclosed by the MCO pursuant to this section, to the extent that such information is confidential under Texas or federal law.
Appears in 7 contracts
Samples: Contract (Centene Corp), Contract (Centene Corp), Contract (Centene Corp)